Promethazine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Promethazine Hydrochloride Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status Current. The shortage was first posted on 11/21/2023. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- XGen Pharmaceuticals DJB, Inc.
- Package NDC
- 39822-5550-6
- Dosage Form
- Injection
- Presentation
- Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)
- Initial Posting
- 11/21/2023
- Revised Date
Reason
Demand increase for the drug